Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs FREDUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA FREDUN PHARMA AUROBINDO PHARMA/
FREDUN PHARMA
 
P/E (TTM) x 14.3 65.3 21.9% View Chart
P/BV x 1.4 9.6 14.7% View Chart
Dividend Yield % 1.5 0.1 2,017.1%  

Financials

 AUROBINDO PHARMA   FREDUN PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
FREDUN PHARMA
Mar-21
AUROBINDO PHARMA/
FREDUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,064597 178.2%   
Low Rs584113 515.8%   
Sales per share (Unadj.) Rs400.3335.6 119.3%  
Earnings per share (Unadj.) Rs45.75.1 905.1%  
Cash flow per share (Unadj.) Rs64.910.1 644.8%  
Dividends per share (Unadj.) Rs9.000.70 1,285.7%  
Avg Dividend yield %1.10.2 554.1%  
Book value per share (Unadj.) Rs419.4107.9 388.6%  
Shares outstanding (eoy) m585.943.99 14,685.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.11.1 194.5%   
Avg P/E ratio x18.070.3 25.6%  
P/CF ratio (eoy) x12.735.3 36.0%  
Price / Book Value ratio x2.03.3 59.7%  
Dividend payout %19.713.9 142.1%   
Avg Mkt Cap Rs m482,7991,417 34,076.5%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50987 39,867.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,5551,339 17,518.1%  
Other income Rs m3,22614 23,090.9%   
Total revenues Rs m237,7811,353 17,575.6%   
Gross profit Rs m42,56682 52,017.2%  
Depreciation Rs m11,26520 56,213.6%   
Interest Rs m48644 1,113.3%   
Profit before tax Rs m34,04032 106,142.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,25612 60,875.0%   
Profit after tax Rs m26,78420 132,921.1%  
Gross profit margin %18.16.1 296.9%  
Effective tax rate %21.337.2 57.4%   
Net profit margin %11.41.5 758.9%  
BALANCE SHEET DATA
Current assets Rs m181,2271,301 13,931.9%   
Current liabilities Rs m81,560865 9,433.7%   
Net working cap to sales %42.532.6 130.4%  
Current ratio x2.21.5 147.7%  
Inventory Days Days253 739.1%  
Debtors Days Days62111,973,591 0.0%  
Net fixed assets Rs m155,104315 49,181.7%   
Share capital Rs m58640 1,468.4%   
"Free" reserves Rs m245,174391 62,734.8%   
Net worth Rs m245,760431 57,060.6%   
Long term debt Rs m2,492291 856.1%   
Total assets Rs m336,3311,616 20,810.3%  
Interest coverage x71.01.7 4,093.5%   
Debt to equity ratio x00.7 1.5%  
Sales to assets ratio x0.70.8 84.2%   
Return on assets %8.14.0 205.3%  
Return on equity %10.94.7 233.0%  
Return on capital %13.910.5 132.5%  
Exports to sales %31.133.0 94.1%   
Imports to sales %11.90.6 2,144.6%   
Exports (fob) Rs m72,862442 16,492.1%   
Imports (cif) Rs m27,9657 375,869.6%   
Fx inflow Rs m77,245442 17,484.2%   
Fx outflow Rs m31,5247 423,705.6%   
Net fx Rs m45,721434 10,526.4%   
CASH FLOW
From Operations Rs m50,1652 2,950,870.6%  
From Investments Rs m-32,116-14 231,380.4%  
From Financial Activity Rs m-29,693-7 416,447.4%  
Net Cashflow Rs m-11,674-19 60,455.7%  

Share Holding

Indian Promoters % 48.8 51.0 95.5%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.0 1.7 2,262.5%  
FIIs % 20.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 49.0 98.4%  
Shareholders   359,684 3,690 9,747.5%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    



Today's Market

Sensex Zooms 130 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.